Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emilio Bria

Showing results (251-260 of 377) with videos related to

Pageof 38
Sort By:
European Journal of Cancer (Oxford, England : 1990)|December 23, 2025
PIK3CA mutations and first-line outcomes in endocrine-resistant HR+/HER2- metastatic breast cancer: A multicentric real-world studyMaria Vittoria Dieci, Grazia Vernaci, Chiara Colangelo, et al.
International Journal of Molecular Sciences|April 14, 2026
LANTERN-XGB: An Interpretable Multi-Modal Machine Learning for Improving Clinical Decision-Making in Lung CancerDavide Dalfovo, Carolina Sassorossi, Elisa De Paolis, et al.
Clinical Lung Cancer|February 9, 2021
PTEN Loss as a Predictor of Tumor Heterogeneity and Poor Prognosis in Patients With EGFR-mutant Advanced Non-small-cell Lung Cancer Receiving Tyrosine Kinase InhibitorsMiriam Grazia Ferrara, Maurizio Martini, Ettore D'Argento, et al.
Anticancer Research|September 12, 2013
HER2/neu gene determination in women screened for breast carcinoma: how screening programs reduce the skyrocketing cost of targeted therapyMatteo Brunelli, Erminia Manfrin, Emilio Bria, et al.
Clinical Lung Cancer|November 21, 2017
Effect of Contract Research Organization Bureaucracy in Clinical Trial Management: A Model From Lung CancerElisa Gobbini, Sara Pilotto, Giulia Pasello, et al.
Cancers|October 21, 2020
The Experience of Oncology Healthcare Providers in the Central Italy during the COVID-19 LockdownAlessandra Fabi, Patrizia Pugliese, Pina Tiziana Falbo, et al.
The Clinical Respiratory Journal|May 4, 2017
Final data of an Italian multicentric survey about counseling for smoking cessation in patients with diagnosis of a respiratory diseaseEnrica Capelletto, Simonetta Grazia Rapetti, Sara Demichelis, et al.
International Journal of Molecular Sciences|September 14, 2024
Comparative Analysis of Comprehensive Genomic Profile in Thymomas and Recurrent Thymomas Reveals Potentially Actionable Mutations for Target TherapiesFilippo Lococo, Elisa De Paolis, Jessica Evangelista, et al.
Expert Opinion on Investigational Drugs|June 28, 2007
Aromatase inhibitors in post-menopausal metastatic breast carcinomaPaolo Carlini, Emilio Bria, Diana Giannarelli, et al.
Clinical Genitourinary Cancer|November 27, 2019
Survival Outcomes From a Cumulative Analysis of Worldwide Observational Studies on Sequential Use of New Agents in Metastatic Castration-Resistant Prostate CancerOrazio Caffo, Michel Wissing, Diletta Bianchini, et al.
Pageof 38

Showing results (251-260 of 377) with videos related to

Sort By:
Pageof 38
European Journal of Cancer (Oxford, England : 1990)|December 23, 2025
PIK3CA mutations and first-line outcomes in endocrine-resistant HR+/HER2- metastatic breast cancer: A multicentric real-world studyMaria Vittoria Dieci, Grazia Vernaci, Chiara Colangelo, et al.
International Journal of Molecular Sciences|April 14, 2026
LANTERN-XGB: An Interpretable Multi-Modal Machine Learning for Improving Clinical Decision-Making in Lung CancerDavide Dalfovo, Carolina Sassorossi, Elisa De Paolis, et al.
Clinical Lung Cancer|February 9, 2021
PTEN Loss as a Predictor of Tumor Heterogeneity and Poor Prognosis in Patients With EGFR-mutant Advanced Non-small-cell Lung Cancer Receiving Tyrosine Kinase InhibitorsMiriam Grazia Ferrara, Maurizio Martini, Ettore D'Argento, et al.
Anticancer Research|September 12, 2013
HER2/neu gene determination in women screened for breast carcinoma: how screening programs reduce the skyrocketing cost of targeted therapyMatteo Brunelli, Erminia Manfrin, Emilio Bria, et al.
Clinical Lung Cancer|November 21, 2017
Effect of Contract Research Organization Bureaucracy in Clinical Trial Management: A Model From Lung CancerElisa Gobbini, Sara Pilotto, Giulia Pasello, et al.
Cancers|October 21, 2020
The Experience of Oncology Healthcare Providers in the Central Italy during the COVID-19 LockdownAlessandra Fabi, Patrizia Pugliese, Pina Tiziana Falbo, et al.
The Clinical Respiratory Journal|May 4, 2017
Final data of an Italian multicentric survey about counseling for smoking cessation in patients with diagnosis of a respiratory diseaseEnrica Capelletto, Simonetta Grazia Rapetti, Sara Demichelis, et al.
International Journal of Molecular Sciences|September 14, 2024
Comparative Analysis of Comprehensive Genomic Profile in Thymomas and Recurrent Thymomas Reveals Potentially Actionable Mutations for Target TherapiesFilippo Lococo, Elisa De Paolis, Jessica Evangelista, et al.
Expert Opinion on Investigational Drugs|June 28, 2007
Aromatase inhibitors in post-menopausal metastatic breast carcinomaPaolo Carlini, Emilio Bria, Diana Giannarelli, et al.
Clinical Genitourinary Cancer|November 27, 2019
Survival Outcomes From a Cumulative Analysis of Worldwide Observational Studies on Sequential Use of New Agents in Metastatic Castration-Resistant Prostate CancerOrazio Caffo, Michel Wissing, Diletta Bianchini, et al.
Pageof 38